SK284601B6 - Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS - Google Patents

Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS Download PDF

Info

Publication number
SK284601B6
SK284601B6 SK586-98A SK58698A SK284601B6 SK 284601 B6 SK284601 B6 SK 284601B6 SK 58698 A SK58698 A SK 58698A SK 284601 B6 SK284601 B6 SK 284601B6
Authority
SK
Slovakia
Prior art keywords
flupirtine
cells
hiv
apoptosis
infected
Prior art date
Application number
SK586-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK58698A3 (en
Inventor
Gabriela Pergande
Werner E. G. M�Ller
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of SK58698A3 publication Critical patent/SK58698A3/sk
Publication of SK284601B6 publication Critical patent/SK284601B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK586-98A 1995-11-07 1996-10-23 Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS SK284601B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19541405A DE19541405A1 (de) 1995-11-07 1995-11-07 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
PCT/DE1996/002009 WO1997017072A2 (fr) 1995-11-07 1996-10-23 Utilisation de flupirtine pour la prophylaxie et le traitement de maladies associees a une alteration du systeme cellulaire hematopoietique

Publications (2)

Publication Number Publication Date
SK58698A3 SK58698A3 (en) 1998-09-09
SK284601B6 true SK284601B6 (sk) 2005-07-01

Family

ID=7776799

Family Applications (1)

Application Number Title Priority Date Filing Date
SK586-98A SK284601B6 (sk) 1995-11-07 1996-10-23 Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS

Country Status (27)

Country Link
US (2) US6034111A (fr)
EP (1) EP0859613B1 (fr)
JP (1) JPH11514652A (fr)
KR (1) KR100512673B1 (fr)
CN (1) CN1116037C (fr)
AT (1) ATE316789T1 (fr)
AU (1) AU711207B2 (fr)
BG (1) BG63149B1 (fr)
BR (1) BR9611588A (fr)
CA (1) CA2189705C (fr)
CZ (1) CZ298115B6 (fr)
DE (2) DE19541405A1 (fr)
DK (1) DK0859613T3 (fr)
ES (1) ES2257755T3 (fr)
HK (1) HK1016508A1 (fr)
HU (1) HU225742B1 (fr)
MX (1) MX9803610A (fr)
NO (1) NO315074B1 (fr)
NZ (1) NZ330414A (fr)
PL (1) PL186537B1 (fr)
PT (1) PT859613E (fr)
RU (1) RU2200555C2 (fr)
SK (1) SK284601B6 (fr)
TW (1) TW393317B (fr)
UA (1) UA51682C2 (fr)
WO (1) WO1997017072A2 (fr)
ZA (1) ZA968783B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
EP1688141A1 (fr) * 2005-01-31 2006-08-09 elbion AG Utilisation de flupirtine pour le traitement de la vessie hyperactive et des maladies associées et pour le traitement du syndrome du colon irritable
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
EP2462253B1 (fr) * 2009-08-07 2021-04-07 Swagelok Company Carburation à basse température sous vide partiel
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
MX2014010460A (es) * 2012-03-02 2014-10-13 Meda Pharma Gmbh & Co Kg Formulaciones farmaceuticas que contienen flupirtina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172468B (fr) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

Also Published As

Publication number Publication date
RU2200555C2 (ru) 2003-03-20
NO981898D0 (no) 1998-04-27
ATE316789T1 (de) 2006-02-15
HU225742B1 (en) 2007-07-30
DK0859613T3 (da) 2006-06-06
BG63149B1 (bg) 2001-05-31
TW393317B (en) 2000-06-11
CN1116037C (zh) 2003-07-30
EP0859613A2 (fr) 1998-08-26
HUP9901659A2 (hu) 1999-09-28
NO315074B1 (no) 2003-07-07
DE59611327D1 (de) 2006-04-13
HK1016508A1 (en) 1999-11-05
WO1997017072A3 (fr) 1997-07-24
EP0859613B1 (fr) 2006-02-01
SK58698A3 (en) 1998-09-09
CA2189705C (fr) 2005-08-09
AU711207B2 (en) 1999-10-07
BR9611588A (pt) 1999-04-06
PL326629A1 (en) 1998-10-12
CZ298115B6 (cs) 2007-06-27
ZA968783B (en) 1997-05-27
CA2189705A1 (fr) 1997-05-08
CZ128398A3 (cs) 1998-09-16
ES2257755T3 (es) 2006-08-01
WO1997017072A2 (fr) 1997-05-15
HUP9901659A3 (en) 2001-04-28
PL186537B1 (pl) 2004-01-30
BG102404A (en) 1998-12-30
US6034111A (en) 2000-03-07
CN1201391A (zh) 1998-12-09
PT859613E (pt) 2006-06-30
NZ330414A (en) 1999-10-28
AU1716597A (en) 1997-05-29
MX9803610A (es) 1998-09-30
KR19990067366A (ko) 1999-08-16
KR100512673B1 (ko) 2005-12-09
DE19541405A1 (de) 1997-05-15
UA51682C2 (uk) 2002-12-16
JPH11514652A (ja) 1999-12-14
US6034112A (en) 2000-03-07
NO981898L (no) 1998-04-27

Similar Documents

Publication Publication Date Title
CA2373883A1 (fr) Procede pour reduire une blessure neuronale ou empecher l'apoptose
Crowe Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection
SK284601B6 (sk) Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS
JPH07173063A (ja) 製薬学的に活性な化合物を含有するマラリヤの治療剤
CA1261272A (fr) Combinaison de produit a dihydropyridine
WO1997017072A9 (fr) Utilisation de flupirtine pour la prophylaxie et le traitement de maladies associees a une alteration du systeme cellulaire hematopoietique
SK24098A3 (en) Combinatory composition for the treatment of dementia
SK50696A3 (en) Flavin and its derivatives as anti-viral agents
JPH0521891B2 (fr)
EP1075270B1 (fr) Peptide court destine au traitement des maladies neurodegeneratives
Rosengarten et al. A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats
EP0476391B1 (fr) Composition anti-SIDA contenant cépharanthine comme agent thérapeutique
US20020198247A1 (en) Pharmaceutical composition for inhibiting the growth of viruses and cancers
Müller et al. Flupirtine protects both neuronal cells and lymphocytes against induced apoptosis in vitro: implications for treatment of AIDS patients
EP0555302A1 (fr) Procede de traitement des maladies demyelinisantes
CA2064112C (fr) Preparations pharmaceutiques a base d'.alpha.-dihydroergocryptine, neuroprotectrices
WO1993025203A1 (fr) Procede de traitement et de protection contre l'ischemie, l'hypoxie, la degenerescence et les traumas du systeme nerveux central au moyen d'une 5-aminocarbonyl-sh-dibenzo[a,d]cyclohepten-5,10-imine
WO2002072025A2 (fr) Reponse postsynaptique amelioree par une combinaison de 4-aminopyridine et agoniste
Dearsly et al. Sexual development in Plasmodium berghei: the use of mitomycin C to separate infective gametocytes in vivo and ookinetes in vitro
NZ242264A (en) Polyadenylic acid/polyuridylic acid complexes in pharmaceutical compositions
HUT58523A (en) Process for producing antiviral compositions from modified gangliosides
CA2251800A1 (fr) Traitement de la demence associee a l'infection par le virus du sida (vih-1) au moyen de pieges a radicaux libres a base de nitrone
WO2007131488A2 (fr) Utilisation de dérivés de quinolone comme agents antiprotozoaires et dans des associations médicamenteuses

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20131023